healthcare.digital November 10, 2025
Executive Summary: The 2026 HealthTech and MedTech Deal Thesis
The Mergers and Acquisitions (M&A) landscape for HealthTech and MedTech is poised for a significant strategic acceleration in 2026, transitioning from cautious, volume-driven dealmaking witnessed in previous years to high-value, transformative transactions.
This resurgence is supported by stabilising credit markets, renewed corporate confidence, and a critical, anticipated pivot in US. antitrust enforcement policy, which is expected to facilitate large, strategic combinations.
The market dynamic is shifting from a focus purely on innovation to one demanding demonstrable return on investment (ROI) derived from technological integration. Private Equity (PE) involvement remains high, supported by robust dry powder reserves, with sponsors focusing on both platform expansion and realising delayed exits into a receptive corporate...
Today's Sponsors
Today's Sponsor